Search Results - "Higazi, Abd Al Roof"
-
1
Endogenous plasminogen activators mediate progressive intracerebral hemorrhage after traumatic brain injury in mice
Published in Blood (16-04-2015)“…Persistent intracerebral hemorrhage (ICH) is a major cause of death and disability after traumatic brain injury (TBI) for which no medical treatment is…”
Get full text
Journal Article -
2
Alpha‐defensins: risk factor for thrombosis in COVID‐19 infection
Published in British journal of haematology (01-07-2021)“…Summary The inflammatory response to SARS/CoV‐2 (COVID‐19) infection may contribute to the risk of thromboembolic complications. α‐Defensins, antimicrobial…”
Get full text
Journal Article -
3
Divergent impacts of tocilizumab and colchicine in COVID‐19‐associated coagulopathy: the role of alpha‐defensins
Published in British journal of haematology (01-02-2022)“…Summary Patients who are severely affected by coronavirus disease 2019 (COVID‐19) may develop a delayed onset ‘cytokine storm’, which includes an increase in…”
Get full text
Journal Article -
4
The plasminogen activator system: involvement in central nervous system inflammation and a potential site for therapeutic intervention
Published in Journal of neuroinflammation (11-10-2013)“…Extracellular proteases such as plasminogen activators (PAs) and matrix metalloproteinases modulate cell-cell and cell-matrix interactions. Components of the…”
Get full text
Journal Article -
5
Characterization of metabolic alterations in the lean metabolically unhealthy alpha defensin transgenic mice
Published in iScience (16-02-2024)“…Inflammation is consistently linked to dysmetabolism. In transgenic mice (Def+/+) model the neutrophilic peptide, alpha defensin, proved atherogenic. This…”
Get full text
Journal Article -
6
Opposing effects of HNP1 (α-defensin-1) on plasma cholesterol and atherogenesis
Published in PloS one (17-04-2020)“…Atherosclerosis, the predominant cause of death in well-resourced countries, may develop in the presence of plasma lipid levels within the normal range…”
Get full text
Journal Article -
7
Alleviation of Hepatic Steatosis by Alpha-Defensin Is Associated with Enhanced Lipolysis
Published in Medicina (Kaunas, Lithuania) (19-05-2023)“…: The neutrophilic peptide, alpha-defensin, is considered an evolving risk factor intimately linked with lipid mobilization. It was previously linked to…”
Get full text
Journal Article -
8
Blood–brain barrier permeability and tPA-mediated neurotoxicity
Published in Neuropharmacology (01-06-2010)“…Tissue type plasminogen activator (tPA) can induce neuronal apoptosis, disrupt the blood–brain barrier (BBB), and promote dilation of the cerebral vasculature…”
Get full text
Journal Article -
9
Insulin and glucagon share the same mechanism of neuroprotection in diabetic rats: role of glutamate
Published in American journal of physiology. Regulatory, integrative and comparative physiology (01-09-2011)“…In patients with acute ischemic stroke, diabetes and hyperglycemia are associated with increased infarct size, more profound neurologic deficits and higher…”
Get more information
Journal Article -
10
Regulation of neovascularization by human neutrophil peptides (α‐defensins): a link between inflammation and angiogenesis
Published in The FASEB journal (01-08-2004)“…ABSTRACT Angiogenesis, the growth of new blood vessels, is a complex biological process that is orchestrated by several growth factors and components of the…”
Get full text
Journal Article -
11
Neutrophil α-Defensins Cause Lung Injury by Disrupting the Capillary-Epithelial Barrier
Published in American journal of respiratory and critical care medicine (01-05-2010)“…The involvement of neutrophil activation in the sentinel, potentially reversible, events in the pathogenesis of acute lung injury (ALI) is only partially…”
Get full text
Journal Article -
12
The fibrinolytic system attenuates vascular tone: effects of tissue plasminogen activator (tPA) and aminocaproic acid on renal microcirculation
Published in British journal of pharmacology (01-03-2004)“…The renal medulla is a major source of plasminogen activators (PA), recently shown to induce vasodilation in vitro. Treatment with PA inhibitors has been…”
Get full text
Journal Article -
13
Urokinase-type Plasminogen Activator (uPA) Induces Pulmonary Microvascular Endothelial Permeability through Low Density Lipoprotein Receptor-related Protein (LRP)-dependent Activation of Endothelial Nitric-oxide Synthase
Published in The Journal of biological chemistry (01-07-2011)“…Urokinase plasminogen activator (uPA) and PA inhibitor type 1 (PAI-1) are elevated in acute lung injury, which is characterized by a loss of endothelial…”
Get full text
Journal Article -
14
Neutralizing the neurotoxic effects of exogenous and endogenous tPA
Published in Nature neuroscience (01-09-2006)“…The clinical use of tissue-type plasminogen activator (tPA) in the treatment of stroke is profoundly constrained by its serious side effects. We report that…”
Get full text
Journal Article -
15
In vitro and in vivo effects of tPA and PAI-1 on blood vessel tone
Published in Blood (01-02-2004)“…Tissue type plasminogen activator (tPA) is a key enzyme in the fibrinolytic cascade. In this paper we report that tPA contains 2 independent epitopes that…”
Get full text
Journal Article -
16
Platelet Factor 4 Enhances the Binding of Oxidized Low-density Lipoprotein to Vascular Wall Cells
Published in The Journal of biological chemistry (21-02-2003)“…Accumulation of low-density lipoprotein (LDL)-derived cholesterol by macrophages in vessel walls is a pathogenomic feature of atherosclerotic lesions…”
Get full text
Journal Article -
17
ACE2, COVID-19 Infection, Inflammation, and Coagulopathy: Missing Pieces in the Puzzle
Published in Frontiers in physiology (06-10-2020)“…Engulfed by the grave consequences of the coronavirus disease 2019 (COVID-19) pandemic, a better understanding of the unique pattern of viral invasion and…”
Get full text
Journal Article -
18
Role of tissue plasminogen activator in clinical aggravation of experimental autoimmune encephalomyelitis and its therapeutic potential
Published in Cellular immunology (01-02-2020)“…•Tissue plasminogen activator (tPA) has immunomodulatory effect in EAE.•Absence of tPA aggravate EAE, while administration of tPA ameliorate the…”
Get full text
Journal Article -
19
Release of IL-6 After Stroke Contributes to Impaired Cerebral Autoregulation and Hippocampal Neuronal Necrosis Through NMDA Receptor Activation and Upregulation of ET-1 and JNK
Published in Translational stroke research (01-02-2019)“…The sole FDA-approved drug treatment for ischemic stroke is tissue-type plasminogen activator (tPA). However, upregulation of JNK mitogen-activated protein…”
Get full text
Journal Article -
20
Platelet factor 4 binds to low-density lipoprotein receptors and disrupts the endocytic itinerary, resulting in retention of low-density lipoprotein on the cell surface
Published in Blood (15-05-2002)“…The influence of platelets on the cellular metabolism of atherogenic lipoproteins has not been characterized in detail. Therefore, we investigated the effect…”
Get full text
Journal Article